Keyphrases
Heart Failure
100%
Angiotensin Receptor-neprilysin Inhibitor
100%
Heart Failure with Preserved Ejection Fraction (HFpEF)
100%
Heart Failure Management
50%
Hospitalization
25%
Advancing Age
25%
Public Health Risk
25%
Pharmacotherapy
25%
Angiotensin-converting Enzyme Inhibitor (ACEi)
25%
Public Healthcare
25%
Health Care Costs
25%
New Therapies
25%
Mortality Costs
25%
Private Healthcare
25%
Cardiac Patients
25%
Clinical Syndromes
25%
Angiotensin II Type 1 Receptor (AT1R)
25%
Neprilysin
25%
Medicine and Dentistry
Congestive Heart Failure
100%
Enkephalinase Inhibitor
100%
Angiotensin Receptor
100%
Heart Failure with Reduced Ejection Fraction
60%
Disease
20%
Health Care
20%
Public Health
20%
Prevalence
20%
Drug Therapy
20%
Health Care Cost
20%
ACE Inhibitor
20%
Heart Failure with Preserved Ejection Fraction
20%
Neprilysin
20%
Clinical Syndrome
20%
Nursing and Health Professions
Angiotensin Receptor
100%
Enkephalinase Inhibitor
100%
Congestive Heart Failure
100%
Heart Failure with Reduced Ejection Fraction
60%
Disease
20%
Drug Therapy
20%
Syndrome
20%
Prevalence
20%
Health Service
20%
Health Care Cost
20%
Dipeptidyl Carboxypeptidase Inhibitor
20%
Heart Failure with Preserved Ejection Fraction
20%
Membrane Metalloendopeptidase
20%
Nutrition Policy
20%